| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |